SGAM
BSTC

Smith Group Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Smith Group Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,601
Closed -$260K – 395
2020
Q1 		$260K Hold
4,601
– – 0.01% 150
2019
Q4 		$262K Hold
4,601
– – 0.01% 177
2019
Q3 		$246K Hold
4,601
– – 0.01% 180
2019
Q2 		$275K Sell
4,601
-415
-8% -$26.1K 0.01% 183
2019
Q1 		$313K Sell
5,016
-495
-9% -$32.7K 0.01% 195
2018
Q4 		$334K Sell
5,511
-633
-10% -$37.8K 0.01% 212
2018
Q3 		$359K Hold
6,144
– – 0.01% 210
2018
Q2 		$276K Buy
6,144
+27
+0.4% +$1.16K 0.01% 225
2018
Q1 		$271K Sell
6,117
-199
-3% -$8.36K 0.01% 228
2017
Q4 		$274K Hold
6,316
– – 0.01% 232
2017
Q3 		$294K Sell
6,316
-500
-7% -$23.9K 0.01% 237
2017
Q2 		$337K Sell
6,816
-2,972
-30% -$156K 0.01% 236
2017
Q1 		$536K Hold
9,788
– – 0.02% 182
2016
Q4 		$545K Sell
9,788
-300
-3% -$14.4K 0.02% 182
2016
Q3 		$461K Buy
10,088
+240
+2% +$9.64K 0.01% 186
2016
Q2 		$393K Buy
9,848
+9,450
+2,374% +$346K 0.01% 199
2016
Q1 		$14K Sell
398
-20
-5% -$734 ﹤0.01% 387
2015
Q4 		$18K Sell
418
-3
-0.7% -$150 ﹤0.01% 399
2015
Q3 		$18K Hold
421
– – ﹤0.01% 334
2015
Q2 		$22K Hold
421
– – ﹤0.01% 318
2015
Q1 		$16K Sell
421
-1,090
-72% -$42.7K ﹤0.01% 372
2014
Q4 		$58K Hold
1,511
– – ﹤0.01% 291
2014
Q3 		$53K Hold
1,511
– – ﹤0.01% 250
2014
Q2 		$41K Hold
1,511
– – ﹤0.01% 276
2014
Q1 		$39K Buy
+1,511
New +$36.2K ﹤0.01% 268

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Smith Group Asset Management's BSTC Position: Q2 2020 in Review

Smith Group Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2020, closing a stake of 4,601 shares — an estimated $260K sold.

Smith Group Asset Management first reported a position in BSTC in Q1 2014 and held it in 25 quarters. The position peaked at $545K in Q4 2016. 116 funds tracked by Wall St. Rank hold BSTC as of Q2 2020.

  • Smith Group Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q2 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 4,601 BioSpecifics Technologies Corp. shares in Q2 2020, an estimated $260K.
  • Smith Group Asset Management first reported a position in BioSpecifics Technologies Corp. in Q1 2014 and held it in 25 quarters.
  • Smith Group Asset Management's BioSpecifics Technologies Corp. position peaked at $545K in Q4 2016.
  • 116 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2020.

Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.